Lv11
92 积分 2023-05-29 加入
Clinical significance of plasma PD-L1(+) exosomes in the management of diffuse large B cell lymphoma
23分钟前
已完结
Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma
50分钟前
已关闭
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
56分钟前
已完结
CAR immune cells: design principles, resistance and the next generation
1小时前
已完结
Daratumumab–lenalidomide and the immunosuppressive budget in myeloma
3个月前
已完结
Myeloid-derived suppressor cells in cancer and cancer therapy
3个月前
已完结
Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy
3个月前
已完结
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT
7个月前
已完结
Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia
7个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
8个月前
已完结
皖公网安备34019202002308
